These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New Aspects Regarding the Fluorescence Spectra of Melanin and Neuromelanin in Pigmented Human Tissue Concerning Hypoxia. Leupold D; Buder S; Pfeifer L; Szyc L; Riederer P; Strobel S; Monoranu CM Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126026 [TBL] [Abstract][Full Text] [Related]
4. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489 [TBL] [Abstract][Full Text] [Related]
5. The enigma of neuromelanin in Parkinson's disease substantia nigra. Youdim MB; Ben-Shachar D; Riederer P J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393 [TBL] [Abstract][Full Text] [Related]
6. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857 [TBL] [Abstract][Full Text] [Related]
7. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mann DM; Yates PO Mech Ageing Dev; 1983 Feb; 21(2):193-203. PubMed ID: 6865505 [TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023 [TBL] [Abstract][Full Text] [Related]
9. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. Enochs WS; Sarna T; Zecca L; Riley PA; Swartz HM J Neural Transm Park Dis Dement Sect; 1994; 7(2):83-100. PubMed ID: 7710667 [TBL] [Abstract][Full Text] [Related]
10. Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein. Fasano M; Giraudo S; Coha S; Bergamasco B; Lopiano L Neurochem Int; 2003 Jun; 42(7):603-6. PubMed ID: 12590943 [TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease. Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135 [TBL] [Abstract][Full Text] [Related]
12. Neuromelanin and Parkinson's disease. Marsden CD J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645 [TBL] [Abstract][Full Text] [Related]
13. Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease. Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ J Parkinsons Dis; 2015; 5(3):561-7. PubMed ID: 26406136 [TBL] [Abstract][Full Text] [Related]
14. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients. Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480 [TBL] [Abstract][Full Text] [Related]
16. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double KL Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302 [TBL] [Abstract][Full Text] [Related]
17. A critical review of the function of neuromelanin and an attempt to provide a unified theory. Nicolaus BJ Med Hypotheses; 2005; 65(4):791-6. PubMed ID: 15949901 [TBL] [Abstract][Full Text] [Related]
18. Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. Aime S; Fasano M; Bergamasco B; Lopiano L; Valente G J Neurochem; 1994 Jan; 62(1):369-71. PubMed ID: 8263538 [TBL] [Abstract][Full Text] [Related]
19. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Zecca L; Tampellini D; Gerlach M; Riederer P; Fariello RG; Sulzer D Mol Pathol; 2001 Dec; 54(6):414-8. PubMed ID: 11724917 [TBL] [Abstract][Full Text] [Related]
20. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease. Zucca FA; Segura-Aguilar J; Ferrari E; Muñoz P; Paris I; Sulzer D; Sarna T; Casella L; Zecca L Prog Neurobiol; 2017 Aug; 155():96-119. PubMed ID: 26455458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]